Mia's Feed
Medical News & Research

Study Shows COVID-19 Pandemic Significantly Increased Mental Health, Malaria, and Heart Disease Burdens

Study Shows COVID-19 Pandemic Significantly Increased Mental Health, Malaria, and Heart Disease Burdens

Share this article

A new study highlights how the COVID-19 pandemic led to significant rises in mental health disorders, malaria in children, and heart disease in older adults, emphasizing the need for resilient healthcare systems and integrated strategies to manage long-term impacts.

2 min read

The COVID-19 pandemic has caused widespread disruptions to healthcare systems worldwide, leading to notable increases in non-COVID-related illnesses and deaths. According to a recent study published by The BMJ, mental health disorders, malaria among young children, and cardiovascular diseases in older adults were among the most affected conditions during this period.

Researchers analyzed data from the Global Burden of Disease Study 2021, encompassing 204 countries and territories, to assess the impact of the pandemic on 174 health conditions across different regions, age groups, and genders. They focused on indicators like incidence, prevalence, mortality, and disability-adjusted life years (DALYs), which measure both the quality and quantity of life.

The findings revealed a 23% increase in new cases of depressive disorders among children aged 5–14 and a 14% rise in malaria-related deaths among children under five between 2020 and 2021. Notably, age-standardized DALY rates for mental health issues such as depression and anxiety increased by 12% and 14%, respectively, with women being particularly impacted.

Prevalence rates for heart disease also climbed, especially among individuals aged 70 and older, with ischemic heart disease reaching 169 per 100,000 and stroke 27 per 100,000 people. Malaria-related death rates increased by 12%, mostly affecting young children in Africa.

The study acknowledges limitations, including data quality disparities across regions, potential underreporting, and delayed diagnoses during the pandemic, which might influence the accuracy of these estimates. Nevertheless, it underscores the importance of strengthening health system resilience, expanding disease surveillance, and adopting integrated, syndemic-informed strategies to better prepare for future health emergencies.

Experts emphasize that future responses must go beyond infection control to address the long-term, indirect health impacts of pandemics. Recommendations include allocating resources for essential health services, reinforcing primary healthcare, and prioritizing vulnerable populations to ensure equitable, comprehensive health recovery.

Ultimately, integrating these insights into health policies could reduce the indirect toll of pandemics, making health systems more robust and fair in safeguarding population well-being amidst crises.

Source: https://medicalxpress.com/news/2025-07-mental-health-disorders-malaria-heart.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Use of GLP-1 Receptor Agonists in Supporting Smoking Cessation and Managing Weight Gain

New research reveals that GLP-1 receptor agonists could facilitate smoking cessation by reducing weight gain and addressing the neurological aspects of addiction. This promising approach offers hope for more effective quit strategies with added health benefits.

Benzaldehyde Inhibits Pancreatic Cancer Spread by Disrupting Critical Protein Interactions

Scientists have discovered that benzaldehyde, a compound with a distinctive aroma, can hinder the spread of pancreatic cancer by disrupting key protein interactions, offering hope for overcoming treatment resistance.

Understanding How the Body Responds to Extreme Conditions to Detect Early Signs of Illness

A groundbreaking study maps how the human body communicates under stress, offering new possibilities for early illness detection through real-time physiological monitoring.

FDA Updates ADHD Medication Labels to Highlight Weight Loss Risks

The FDA has updated ADHD medication labels to warn about the increased risk of weight loss and side effects in children under 6, emphasizing safer prescribing and monitoring practices.